doi: 10.3390/cancers13164013 58 Di BiaseSLeeCBrandhorstSManesBBuonoRChengCWet al
For example, in the STEP 1 trial , patients taking semaglutide lost an average of 14.9% of their body weight over 68 weeks , compared with just 2.4% in the placebo group (NEJM study)
GLP-1 Boost helps restore natural hunger cues while gently lifting energy and motivation, making it easier to snack less and stay on track.* SUPPORT WEIGHT MANAGEMENT FOR LONG-TERM SUCCESS: Unlike crash diet pills, injections, or trendy supplements, GLP-1 Boost is designed for daily use
Management strategies include smaller frequent meals, texture modifications, adequate hydration, and gradual dose titration under medical supervision
A medication that feels easier to take consistently may ultimately produce better long-term outcomes
Viral infections exacerbate FUS-ALS phenotypes in iPSC-derived spinal neurons in a virus species-specific manner